PATENT CLAIM ANALYSIS

Application Number: 16131110
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "143100"]

Abstract:
The present invention generally relates to antibodies specific for asialoglycoprotein receptor (ASGPR) and their use for selectively delivering effector moieties that influence cellular activity. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies of the invention, and to methods of using them in the treatment of disease.

Claim (Index 11):
The affinity matured variant antibody of  claim 7 , comprising an effector moiety attached to the antibody, wherein the effector moiety is a cytokine molecule.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 97.0
- Lexical Diversity: 1.63043
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14419824', '15711495', '15067024', '13205743', '15879260']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8037014285836903
- 35 USC 102 Novelty (BERT): 0.602728262487631
- Combined Prediction Score: 0.7836041119740844
- Mean Citation Score: 481.664678
- Max Citation Score: 651.7915
- Similarity Product: 449.09351889055966

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test